Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Yangle Huang"'
Autor:
Xiaomin Ou, Wenbin Yan, Yangle Huang, Xiayun He, Hongmei Ying, Xueguan Lu, Hui Zhu, Bin Wu, Jiazhou Wang, Chaosu Hu
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Backgrounds Despite publication of international guidelines, there are notable controversial points of clinical target volume (CTV) delineation in nasopharyngeal carcinoma (NPC). Recently, scholars proposed a novel way of delineation of CTV
Externí odkaz:
https://doaj.org/article/fdbeeb444b5048a5b9a9e044395b110a
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundHeavy ion radiotherapy, such as carbon ion radiotherapy (CIRT), has multiple advantages over conventional photon therapy. Cisplatin, as a classic anti-tumor drugs, has been tested and discovered as a photon radiosensitizer in several cell l
Externí odkaz:
https://doaj.org/article/7cf3ddfcbeea47d9b445308a98b03ded
Autor:
Qingting Huang, Yun Sun, Weiwei Wang, Lien-Chun Lin, Yangle Huang, Jing Yang, Xiaodong Wu, Lin Kong, Jiade Jay Lu
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Recently, a growing number of studies focus on partial tumor irradiation to induce the stronger non-target effects. However, the value of partial volume carbon ion radiotherapy (CIRT) targeting hypoxic region of a tumor under imaging guidance as well
Externí odkaz:
https://doaj.org/article/9d13bcb5de4d495e943c7c9b1996753a
Autor:
Yangle Huang, Qingting Huang, Jingfang Zhao, Yuanli Dong, Lijia Zhang, Xumeng Fang, Pian Sun, Lin Kong, Jiade Jay Lu
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
IntroductionHypoxia is a hallmark of cancer that may contribute to an immunosuppressive microenvironment and promote radioresistance. High linear energy transfer (LET) radiation is considered to be able to overcome the negative effects of hypoxia. Ho
Externí odkaz:
https://doaj.org/article/2e12a141cc6c4e99ad030bab476f6ec7
Autor:
Xiaofeng Xu, Peiru Zhang, Yangle Huang, Weizhong Shi, Jingfang Mao, Ningyi Ma, Lin Kong, Lin Guo, Jinlong Liu, Jian Chen, Renquan Lu
Publikováno v:
Cancer Science. 114:105-114
Lung cancer is one of the leading causes of death among cancer patients worldwide. Carbon-ion radiotherapy is a radical nonsurgical treatment with high local control rates and no serious adverse events. N6-methyladenosine (m6A) modification is one of
Publikováno v:
Translational Cancer Research
Background Glioma accounts for 70% of primary brain malignancies in adults with unfavorable prognoses. In the past decades, much efforts have been invested to identify better biomarkers for predicting prognoses. Recently, necroptosis has been reporte
Autor:
Cihang Bao, Jiade J. Lu, Bilikere S. Dwarakanath, Yun Sun, Chandan Guha, Yuanli Dong, Xiaodong Wu, Lin Kong, Yangle Huang
Publikováno v:
Journal of Cancer
To explore the potential and mechanisms of necroptosis, a form of immunogenic cell death, induced by carbon ion as compared to photon beams in established photon resistant- (PR-) and sensitive nasopharyngeal carcinoma (NPC) cells. MLKL is considered
Autor:
Bilikere S. Dwarakanath, Lin Kong, Yun Sun, Xumeng Fang, Pian Sun, Jiade J. Lu, Yuanli Dong, Yangle Huang
Publikováno v:
Ann Transl Med
Background: To examine whether MLKL participated in the invasion of radiosensitive nasopharyngeal carcinoma (NPC) cell (CNE-2) and radioresistant NPC cell (CR) through regulating epithelial-mesenchymal transition (EMT). Methods: siRNA and CRISPR/Cas9
Autor:
Lingdun Zhuge, Jie Zhang, Yawei Zhang, Juntao Xie, Jiaqing Xiang, Sufeng Chen, Yangle Huang, Haiquan Chen, Toni Lerut, Hong Hu, James D. Luketich, Longlong Shao, Shengfei Wang, Yihua Sun
Publikováno v:
Surgical Endoscopy. 32:1441-1448
Although endoscopic resection (ER) may be sufficient treatment for early-stage esophageal cancer, additional treatment is recommended when there is a high risk of cancer recurrence. It is unclear whether delaying esophagectomy by performing and asses
Publikováno v:
Annals of Translational Medicine. 7:542-542
Background: Accumulating evidence suggested that radiotherapy can activate anti-tumor immune responses by triggering immunogenic cell death (ICD) of tumor cells. Calreticulin is regarded as one of the most important markers of ICD. The cell surface t